Warning: Parameter 1 to wp_default_styles() expected to be a reference, value given in /home/perfaction/public_html/wp-includes/plugin.php on line 601

Warning: Parameter 1 to wp_default_scripts() expected to be a reference, value given in /home/perfaction/public_html/wp-includes/plugin.php on line 601
About – AirGent2.0


The Company

PerfAction Technologies, the original developer and undisputed market leader in intradermal remodeling, is pioneering new treatment modalities for aesthetics and dermatological applications. The AirGent2.0 and EnerJet2.0 platforms brings together the company’s proprietary Jet Volumetric Remodeling (JVR) technology, that simultaneously delivers Kinetic Energy and a Healing Compound, to create a unique micro-trauma profile and optimal spread of the compound

The Medical Aesthetics market is growing a double digit rate, but markets are saturated with Lasers, IPLs, RFs and more. The EnerJet offers an innovative new approach that is a synergy between injectables and devices. This energetic innovation provides for a non-surgical facelift solution, a simple neck lines treatment and an exceptional acne scars elimination treatment.

JVR technology is versatile and effective. It allows development of a single platform with numerous indications. While JVR technology currently offers a range of solutions in aesthetic medicine, it has the potential to be the foundation for new compound-delivery method across an unlimited range of disciplines beyond dermatology and plastic surgery.

JVR technology is ushering in a new era in aesthetic medicine and intradermal compound delivery.



Shy Zyman, CEO

Shy has over two decades of experience in business development, sales and marketing in the high-tech sector. He is the former CEO of two start-up companies and co-founded a leading business development firm. As a senior VP for International Sales at Viora, he enjoyed outstanding success. His experience in the Medical Device market and emerging Medical Aesthetics is driving EnerJet’s emergence as a leading compound delivery platform with huge potential.

Shiri Moskovich, CPA, Chief Financial Officer

Shiri is a Certified Public Accountant with an MBA degree specialization in finance and over a decade of experience working with both privately-held and publically-traded companies. Before joining the EnerJet team, she worked at Price Waterhouse, gaining extensive experience in accounting, maintaining and auditing financial records, managing budgets, risk assessment and business strategy.


Ariel Nezry, Vice President of Marketing & Sales

Ariel joined the EnerJet team in 2014 after ten years of success as VP of Marketing & Sales for SharpLight Technologies, an aesthetic device company. Ariel holds a degree in Business Management degree from the Open University in Israel.

Hagai Sroussi, Vice President R&D

With a degree in mechanical Engineering from the prestigious Technion-Israel institute of Technology, Hagai brings valuable expertise and experience to the EnerJet team in multi-disciplinary R&D and product development, specializing in medical devices.


Ziv Toledano, Chief Operating Officer

Ziv joined the EnerJet team in 2010 as the Service Director, before he quickly moved on to become the Manufacturing Manager. He held that position for four years, leading development, implementation and integration teams through development and launch of the company’s products.

Dr. Yuri Vinshtok, Director of Clinical Research

Dr. Yuri Vinshtok currently serves as Clinical Research Director at PerfAction Technologies. For the past ten years, Dr. Vinshtok held clinical management positions in various medical device and pharma companies including Deep Breathe, Medispec, Urogen (former TheraCoat). Dr. Yuri Vinshtok graduated from the medical school (Russia) in 1984 and brings over 20 years of experience in practical medicine. In addition, he holds Master of Public Administration degree from the City University of New York (USA).


Board of Directors


Alon Maor, Chairman

Alon Maor brings an extensive background in healthcare and medical aesthetics to PerfAction, with over 22 years’ experience in the medical device business.
in 2004, Alon founded Aesthera Corporation – a Kleiner Perkins-backed innovator of light-based technologies for skin treatments. He was CEO and Chairman from Aesthera’s inception through its acquisition by Solta Medical in 2010. Prior to this, he was Executive Vice President and General Manager of the Aesthetic Business Unit at Lumenis. Previously, he established ESC’s Asia operations, acting as CEO and growing the business to $38 million. Before this, Alon spent 10 years at Direx Medical Systems, during which he established Direx Japan as a leading player in diagnostic and therapeutic systems.

Amnon Harari

Amnon Harari is the head of the space administration in the Defense Ministry. Amnon had joined PerfActions Board of Directors in 2011. Before, he served as Lumenis SVP R&D and VP Sales & Service EMEA. Amnon holds a degree in Physics and has years of experience in medical devices research and development, service and sales.


Shai Levi

Mr. Shai Levy has been the CEO of ProSeed Venture Capital Fund Ltd (traded on the Tel Aviv Stock Exchange as TLV:PRSD) since 2012. Mr. Levy has a key role in managing ProSeed fund’s investments, deal flow, financing and M&A as well as serving on a variety of companies Board of Directors in a wide range of industries.

Mr. Levy gained broad-based management experience with investments in the U.S, Europe and Israel in various sectors mostly focusing on High-Tech, Real Estate and Family Office.

Prior to Joining ProSeed, Mr. Levy served as the Chief Financial & Investment Officer for the Tahari Family in New York for over 5 years, as Director of Financial Reporting & Compliance at the Deutsch Inc, New York (a part of Interpublic Group NYSE:IPG), auditor at PwC, New York and at Ernst and Young Israel.

Mr. Levy holds a Bachelor’s degree in Accounting and Finance from Tel-Aviv University and is a Certified Public Accountant (CPA) in Israel.

Dr. Adina Makover

Dr. Adina Makover currently holds the position of Director of Life Sciences Investments at Proseed VC and serves as a director of the board at several public and private companies. Previously, Dr. Makover has been the managing director of Tzina Bio Perspective, a private investment company focusing on biotechnology and medical device ventures. The investment career follows senior management positions in biotech and device companies, focusing on drugs, diagnostics and tissue engineering, holding positions of CEO, R&D, process development and production manager.

Dr. Makover holds a joint PhD degree in life sciences from Columbia University (USA) and Weizmann Institute of Science (Israel) and performed post-doctoral research at the Weizmann Institute of Science. Dr. Makover also holds an MBA degree from Bar-Ilan University.


Yacha Sutton

Yacha brings to PerfAction over 30 years’ experience in the field of Medical Equipment. In 1981 assisted in the IPO of Laser Industries on Nasdaq and joined the Board of Directors and the Executive Committee of the Company. In 1990 joined Laser Industries as Executive Vice President & CFO and in 1995 was appointed President and COO. Company sold in February 1998 for $270M to ESC Medical Systems. In 1999 was asked to assume the CEO position of ESC Medical Systems. Conducted a major restructuring program and turned the company to profitability in 2000. Led a major acquisition in 2001 of the Coherent Medical Group. In last ten years President of Rugby Investments Ltd, a self owned company that invests in startup companies primarily in Medical Equipment.

Advisory Board


Prof. Daniel Cassuto, Plastic Surgeon, Milano, Italy

Plastic Surgeon and a professor of Plastic, Reconstructive and Aesthetic Surgery. He runs a private practice in Milan and serves at the Plastic Surgery Department, University Hospital of Modena, focusing on the treatment of complications from the use of dermal fillers.

Dr. Ofir Artzi, Dermatologist, Israel

Dr. Ofir Artzi is a specialist of dermatology, aesthetic medicine and laser treatments. Graduate of the prestigious medical school in the Technion-Israel institute of Technology. With years of experience in aesthetic medicine and lasers in Israel and worldwide, he is now one of the leading figure locally and globally. As Head of the center for aesthetic dermatology in Ichilov – Tel Aviv Medical center, he specializes in various scar treatments, vascular lesions, hyperhidrosis and anti-aging.


Dr. Alex Levenberg, Plastic Surgeon, Israel

One of the leading plastic surgeons in Israel, certified by the university of Milan. For the past 20 years, he has specialized in plastic surgery of the face , breast , liposuction , chemical peels and laser peel and various injections. He is a member of the Israeli Association of Plastic Surgery and to his record during the last decades thousands of successful surgeries , injections and cosmetic treatments.

Dr. Pablo Naranjo
Medical director for elite laser clinic, Madrid Spain
Vice President of the Spanish Association of Aesthetic Medical Laser

Certified by the Complutense university of Madrid and currently serves as the European Medical Director of the prestigious laser technology for dermatology and aesthetic Syneron- Candela and also as a medical director of the Elite Laser Clinic in Madrid. He is considered to be one of the largest national and international experts in laser technology, ultrasonic and RF technologies for aesthetic medicine and dermatology.


Dr. Tapan Patel, Founder & Medical director of PHI clinic, London, England.

Practicing cosmetic dermatology for the last 14 years, and specialize in a full range of procedures such as using injectables to give subtle natural results, laser procedures, treating patients with skin of color and treating scars.

Dr. Ofer Sharon, President & CO founder of Valera Health

Physician and entrepreneur with extensive experience in both clinical and commercial product development for startups in health tech, biotech, and medical devices. As the former Medical Director for Merck Israel, he founded a big data research collaboration between the pharmaceutical industry and a large payer.


Dr. Greg Goodman, MBBS, FACD, MD.

Dr. Goodman has been a practicing dermatology for more than 20 years. His areas of specialty include skin cancers, Mohs micrographic surgery, lasers in dermatology, cosmetic dermatology, facial aging and the treatment of acne and acne scarring.
He is an associate professor at Monash University in Melbourne, Australia. He is chief of surgery at the Skin and Cancer Foundation of Victoria.

A site byrazgroup